Compound Detail
CHEMBL5093699
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
COc1cc(OC)c2c(c1)O[C@@H](c1cc(OC)c(OC)c(OC)c1)[C@H](OC(=O)c1ccc(F)c(NC(=O)c3cc(OC)c(OC)c(OC)c3)c1)C2
Basic Information
| ChEMBL ID | CHEMBL5093699 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | VNMQONKZFZQPCT-SAIUNTKASA-N |
1
Targets
2
Activities
2
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
707.7
MW (Da)
6.05
ALogP
12
HBA
1
HBD
138.5
PSA (Ų)
0.16
QED
3
Ro5 Violations
13
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
EC50 1 meas. best 6.87
IC50 1 meas. best 8.57
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Unchecked | IC50 | = | 2.7 | nM | 8.57 | Reversal of Pgp-mediated paclitaxel resistance in human LCC6MDR cells assessed a... | 34597896 |
| Unchecked | EC50 | = | 135.0 | nM | 6.87 | Reversal of P-glycoprotein mediated drug resistance in human LCC6MDR cells asses... | 34597896 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 34597896 | 10.1016/j.ejmech.2021.113795 | Unchecked | 3 |
| 34597896 | 10.1016/j.ejmech.2021.113795 | L929 | 1 |
| 34597896 | 10.1016/j.ejmech.2021.113795 | ADMET | 1 |
Data from ChEMBL 36 via Core Engine